The oncology market always has the highest investment in R&D; the Primira investment into ErgoMed and PrimeVigilance will capitalize on this. We wish Ergomed all the success in the world for 2026. Check them out at www.ergomedcro.com.
The oncology market always has the highest investment in R&D; the Primira investment into ErgoMed and PrimeVigilance will capitalize on this. We wish Ergomed all the success in the world for 2026. Check them out at www.ergomedcro.com.
As part of our New Year’s wishlist, we wish Bio X Cell, led by one of our favorite CEOs, Chris Conway, continued double-digit growth in 2026. Check them out at www.bioxcell.com.
Ampersand Capital has been the leading PE in CDMO/CRO middle market investments for the past 10 years. That’s Nice looks to continue to support the team in 2026 and beyond. Check them out at www.ampersandcapital.com.
With a recent round of financing, CellFE continues to push against sector headwinds with great gusto. Our team is rooting for you guys in 2026. Check them out at www.cellfebiotech.com.
Our friends at the specialty application CDMO, Experic, will launch their first commercial product in 2026. Congratulations to Dave Wood and his team! We wish you all the best in 2026. Check them out at www.expericservices.com.
Our team is thankful for the last two years with Bettina and the management team from Coriolis Pharma in Germany. Here’s to continuing to build.
Very, very excited about the launch of the new Recipharm site. Check ’em out at www.recipharm-ab.com.
That’s Nice is pleased to be able to support Kent Payne, Ph.D. and the Curewell Capital team with their recent majority investment into WPT. Big things are on the horizon, so keep your eyes on www.wilmingtonpharmatech.com.
Our team is feeling pretty smug about how the animations on Cellbri’s new website turned out. Check them out at www.cellbri.com.
Excited to also launch the new Cellbri website, complete with interactive web tools for building the perfect custom platform for your cell therapy. Check them out at www.cellbri.com.